Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
07/07/2004 | EP1434863A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS |
07/07/2004 | EP1434862A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns |
07/07/2004 | EP1434858A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
07/07/2004 | EP1434789A2 Improved protein disaggregation and refolding using high pressure |
07/07/2004 | EP1232249B1 Duck pneumovirus and corresponding vaccines |
07/07/2004 | CN1511190A Composition and methods useful for HCV infection |
07/07/2004 | CN1510130A Attenuated cattle viral diarrhoea virus |
07/07/2004 | CN1510129A Structure for recombinant adenovirus with double killer function and application in tumor treatment |
07/07/2004 | CN1509764A Preparation of target gene virus medicine against cancers |
07/06/2004 | US6759231 Kit for in transform and expression of heterologous gene in bacterial |
07/06/2004 | US6759229 Contacting a bacterial cell lysogenic for the selected bacteriophage genome with the isolated nucleic acid molecule such that the isolated nucleic acid is introduced into the bacterial cell; allowing it to recombine with genome |
07/01/2004 | WO2004055216A2 Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells |
07/01/2004 | WO2004055167A2 Alphavirus particles and methods for preparation |
07/01/2004 | WO2004055166A2 Multi-antigenic alphavirus replicon particles and methods |
07/01/2004 | WO2004055161A2 Large scale production of packaged alphavirus replicons |
07/01/2004 | WO2004054613A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
07/01/2004 | WO2004020600A3 Modified aav |
07/01/2004 | WO2004011489A3 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
07/01/2004 | WO2003092582A3 Chimeric ebola virus envelopes and uses therefor |
07/01/2004 | WO2003091386A3 A new family of picornaviruses |
07/01/2004 | US20040126880 Using gamma radiation to inactivate, decrease and/or remove contaminants associated with functioning biological materials, biochemical entities and biologically active molecules and storing materials at room temperature |
07/01/2004 | US20040126869 Method of producing infectious reovirus |
07/01/2004 | US20040126753 Process for producing viral rna polymerase |
07/01/2004 | US20040126388 Measurement genome reproduction of virus; linked to reproter compound; high speed screening for Hepatitis virus |
07/01/2004 | CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
07/01/2004 | CA2807515A1 Alphavirus particles and methods for preparation |
07/01/2004 | CA2510227A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
07/01/2004 | CA2509979A1 Alphavirus particles and methods for preparation |
07/01/2004 | CA2509973A1 Multi-antigenic alphavirus replicon particles and methods |
06/30/2004 | EP1433851A2 Improved expression of HIV polypeptides and production of virus-like particles |
06/30/2004 | EP1433846A2 Phagemid-based method of producing filamentous bacteriophage particles displaying antibody molecules and the corresponding bacteriophage particles. |
06/30/2004 | EP1433483A1 Reovirus for the treatment of neoplasia wherein double stranded RNA-activated protein kinase (PKR) is inactivated or deleted |
06/30/2004 | EP1432791A1 Alphavirus replicon vector systems |
06/30/2004 | EP1169063B1 Treatment of intracellular infection |
06/30/2004 | EP1007637B1 Methods for increasing the efficiency of recombinant aav product |
06/30/2004 | EP1002055B1 Recovery of virus from cell culture using a hypertonic salt solution |
06/30/2004 | EP0724643B1 Endosomolytically active particles |
06/30/2004 | CN1155710C Recombinant herpesvirus with the use of gB Gene promoter |
06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
06/29/2004 | US6756203 Assays for compounds that modulate rhadino virus LANA action in trans on a unit of rhadino virus DNA to mediate efficient episome persistence |
06/29/2004 | US6756198 Nucleotide sequences for use in the treatment of and prevention of viral infections |
06/29/2004 | US6756044 Heightening response of immune effector cells |
06/24/2004 | WO2004053115A1 Magnetism based rapid cell separation |
06/24/2004 | WO2004052278A2 Escape mutants of newcastle disease virus as marker vaccines |
06/24/2004 | WO2004052274A2 Production of bacteriophage compositions for use in phage therapy |
06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
06/24/2004 | WO2003093461A8 Genomic library of cyanophage s-2l and functional analysis |
06/24/2004 | WO2003072716A3 Sequence analysis of the tetravalent rotavirus vaccine |
06/24/2004 | US20040121976 Anti-inflammatory vectors |
06/24/2004 | US20040121466 Alphavirus RNA replicon systems |
06/24/2004 | US20040121465 Optimization of gene sequences of virus-like particles for expression in insect cells |
06/24/2004 | US20040121444 Method of preparing recombinant adeno-associated virus compositions |
06/24/2004 | US20040120972 equine abortion virus mutant |
06/24/2004 | US20040120969 The pure isolate does not suffer from the disadvantages of potential batch to batch variation between substrains and provides a product which is easier to ensure will meet consistent quality guidelines |
06/24/2004 | US20040120929 Defective lentivirus pseudotyped with a lyssavirus envelope; selective transfer of genes into astrocytes of central nervous system; nervous system and brain disorders; viral diseases |
06/24/2004 | CA2507592A1 Magnetism based rapid cell separation |
06/23/2004 | EP1430137A2 Porcine adenovirus e1 and e4 regions |
06/23/2004 | EP1430127A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
06/23/2004 | CN1506460A Method and kit for separating cell particle from sample |
06/23/2004 | CN1154744C Retroviral vectors that containing none of viral coding sequences |
06/23/2004 | CN1154743C Amphotropic retrovirus packaging cell line, process for its production and use thereof |
06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
06/22/2004 | US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences |
06/22/2004 | CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
06/17/2004 | WO2004050843A2 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
06/17/2004 | WO2004050829A2 Recombinant double-stranded rna phage, and use of the same |
06/17/2004 | WO2004050680A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
06/17/2004 | WO2004011677A3 Viral marker |
06/17/2004 | US20040116660 Identifying lymphadenopathy associated viral variants and using sequence homologies in envelope proteins to generate concensus sequence for use in developing vaccine aganist infection; immunotherapy; viricides |
06/17/2004 | US20040116368 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency |
06/17/2004 | US20040115788 Hybrid adeno-retroviral vector for the transfection of cells |
06/17/2004 | US20040115170 reducing viability of a tumor cell by administering a non-naturally occuring reovirus expressing a particular mu-2 protein or a virus capable of expressing the reovirus mu-2 protein |
06/17/2004 | CA2508378A1 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
06/17/2004 | CA2485341A1 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
06/16/2004 | EP1428887A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
06/16/2004 | EP1428886A1 Improved retroviral vectors for gene therapy |
06/16/2004 | EP1427836A2 Pseudotyped retroviral vector system |
06/16/2004 | EP1427835A1 Method for purification of viral vectors having proteins which bind sialic acid |
06/16/2004 | EP1427823A2 High throughput directed evolution by rational mutagenesis |
06/16/2004 | EP1427817A1 Multiplication of viruses in a cell culture |
06/16/2004 | EP1427816A1 Site-specific recombinase based method for producing adenoviral vectors |
06/16/2004 | EP1427815A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
06/16/2004 | EP1427752A2 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
06/16/2004 | EP1427444A2 West nile vaccine |
06/16/2004 | EP0789563B1 Hepatitis virus b and c vaccines |
06/16/2004 | EP0580737B1 Heterodimeric receptor libraries using phagemids |
06/16/2004 | CN1504566A Immunology epitope of hog cholera virus feature and application thereof |
06/15/2004 | US6750043 Expression vector for use in the expression of heterologous protein in cells |
06/15/2004 | US6750009 Multiple viral replicon culture systems |
06/15/2004 | US6749857 Recombinant dimeric envelope vaccine against flaviviral infection |
06/10/2004 | WO2004048543A2 Methods and compositions for controlling valency of phage display |
06/10/2004 | WO2004048402A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
06/10/2004 | WO2004047812A1 Hollow nanoparticles of protein and drug using the same |
06/10/2004 | WO2004037202A9 Gb virus c and methods of treating viral infections |
06/10/2004 | WO2004032959A3 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
06/10/2004 | US20040110269 Protection against mycobacterial infections |
06/10/2004 | US20040110266 Using high performance liquid chromatography to isolate adeno-associated virus particles from cultures; genetic engineering and gene transfer tools |
06/10/2004 | US20040109877 Rna viruses; attenuation influenza virus |
06/10/2004 | US20040109873 Genetic engineering equine herpes virus; genes coding protein |